{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : true,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006955",
      "entity_text" : "immunity",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "interpro:IPR001759",
      "entity_text" : "PTX",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The data demonstrates that the PTX / alphaGC-TH-Lip not only possess therapeutic effect against highly malignant B16F10 melanoma tumor, but also adjust the in vivo immune status and induce a more remarkable systemic antitumor immunity that could further suppress the growth of tumor at distant site.",
  "reading_complete" : "2020-08-02T17:07:36Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T17:04:05Z",
  "trigger" : "induce",
  "evidence" : [ "PTX/alphaGC-TH-Lip not only possess therapeutic effect against highly malignant B16F10 melanoma tumor, but also adjust the in vivo immune status and induce a more remarkable systemic antitumor immunity" ],
  "pmc_id" : "5039686",
  "score" : 0
}